APA

Vincent J., Nadel S., Kutsogiannis D. J., Gibney R. T. N., Yan S. B., Wyss V. L., Bailey J. E., Mitchell C. L., Sarwat S., Shinall S. M. & Janes J. M. (20060926). Drotrecogin alfa (activated) in patients with severe sepsis presenting with purpura fulminans, meningitis, or meningococcal disease: a retrospective analysis of patients enrolled in recent clinical studies. : Critical care (London, England).

Chicago

Vincent Jean-Louis, Nadel Simon, Kutsogiannis Demetrios J, Gibney R T Noel, Yan S Betty, Wyss Virginia L, Bailey Joan E, Mitchell Carol L, Sarwat Samiha, Shinall Stephen M and Janes Jonathan M. 20060926. Drotrecogin alfa (activated) in patients with severe sepsis presenting with purpura fulminans, meningitis, or meningococcal disease: a retrospective analysis of patients enrolled in recent clinical studies. : Critical care (London, England).

Harvard

Vincent J., Nadel S., Kutsogiannis D. J., Gibney R. T. N., Yan S. B., Wyss V. L., Bailey J. E., Mitchell C. L., Sarwat S., Shinall S. M. and Janes J. M. (20060926). Drotrecogin alfa (activated) in patients with severe sepsis presenting with purpura fulminans, meningitis, or meningococcal disease: a retrospective analysis of patients enrolled in recent clinical studies. : Critical care (London, England).

MLA

Vincent Jean-Louis, Nadel Simon, Kutsogiannis Demetrios J, Gibney R T Noel, Yan S Betty, Wyss Virginia L, Bailey Joan E, Mitchell Carol L, Sarwat Samiha, Shinall Stephen M and Janes Jonathan M. Drotrecogin alfa (activated) in patients with severe sepsis presenting with purpura fulminans, meningitis, or meningococcal disease: a retrospective analysis of patients enrolled in recent clinical studies. : Critical care (London, England). 20060926.